Company:  OPGEN INC (OPGN)
Form Type:  424B5
Filing Date:  10/15/2021 
CIK:  0001293818 
Address:  9717 KEY WEST AVENUE
SUITE 100
 
City, State, Zip:  ROCKVILLE, Maryland 20850 
Telephone:  240-813-1260 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$1.55  
Change: 
-0.065 (-4.04%)  
Trade Time: 
12:20 PM EST  
Market Cap: 
$60.18M
Trade OPGN now with

© 2021  
Description of Business
Please refer to the Glossary at the end of this Business section for definitions or descriptions of scientific, diagnostic, healthcare, regulatory, and OpGen-specific terms used in this Annual Report. Overview OpGen, Inc. (the "Company") is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. The Company is developing molecular information products and services for global healthcare settings, helping to guide clinicians with more rapid and actionable information about life threatening infections, improve patient outcomes, and decrease the spread of infections caused by MDROs. OpGen's proprietary DNA tests and informatics address the rising threat of antibiotic resistance by helping physicians and other healthcare providers optimize care decisions for patients with acute infections.
Register and access this filing in:     
  FORM 424B5
    TABLE OF CONTENTS
    ABOUT THIS PROSPECTUS SUPPLEMENT
    SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
    THE OFFERING
    RISK FACTORS
    USE OF PROCEEDS
    DIVIDEND POLICY
    CAPITALIZATION
    DESCRIPTION OF SECURITIES
    PLAN OF DISTRIBUTION
      Indemnification
    LEGAL MATTERS
    EXPERTS
    WHERE YOU CAN FIND MORE INFORMATION
    RISK FACTORS
    USE OF PROCEEDS
    DESCRIPTION OF SECURITIES